HF
TARA icon

HRT Financial’s Protara Therapeutics TARA Stock Holding History

HRT Financial’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,260
Closed -$193K – 4699
2025
Q4 		$193K Buy
+36,260
New +$202K ﹤0.01% 2649
2021
Q3 		– Sell
-12,151
Closed -$118K – 3742
2021
Q2 		$118K Buy
+12,151
New +$138K ﹤0.01% 2551
2020
Q3 		– Sell
-7,339
Closed -$215K – 2331
2020
Q2 		$215K Buy
+7,339
New +$227K 0.01% 1130

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

HRT Financial's TARA Position: Q1 2026 in Review

HRT Financial sold out of Protara Therapeutics (TARA) in Q1 2026, closing a stake of 36,260 shares — an estimated $193K sold.

HRT Financial first reported a position in TARA in Q2 2020 and held it in 3 quarters. The position peaked at $215K in Q2 2020. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • HRT Financial reported no remaining Protara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 36,260 Protara Therapeutics shares in Q1 2026, an estimated $193K.
  • HRT Financial first reported a position in Protara Therapeutics in Q2 2020 and held it in 3 quarters.
  • HRT Financial's Protara Therapeutics position peaked at $215K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.